6505--Naproxen Tablets 8-1-2026 - 7-31-2027

Solicitation / RFP / RFQ

This document is a solicitation for Naproxen Tablets with a period of performance from August 1, 2026, to July 31, 2027. The contracting office is the Department of Veterans Affairs, National Acquisition Center, located in North Chicago, IL (ZIP 60141).

• Procurement of Naproxen Tablets.

• The award number is 36E79726D0029.

• The award amount was $12,991,005.00.

• The award date was April 16, 2026.

• The awardee is RADHA PHARMACEUTICALS INC.

• The contractor's UEI is C1S5SQ88KY67.

• The awardee's address is 330 OSER AVE, HAUPPAUGE, NY 11788.

• Not specified in the provided text.

• NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing).

• Product Service Code: 6505 (Medical and Surgical Equipment).

• The solicitation number is 36E79726R0011.

• The point of contact for this solicitation is Michael Olszewski (michael.olszewski@va.gov, 708-786-4966).

Solicitation / RFP / RFQ

This solicitation seeks proposals for the supply of various Naproxen tablet formulations (250mg, 375mg, and 500mg) in different bottle sizes (100 and 500 tablets). The contract will establish national contract prices for these pharmaceuticals, which will be distributed through the VA and DoD Pharmaceutical Prime Vendor (PPV) Programs. The objective is to ensure nationwide availability and consistent product supply with volume-based pricing.

• Products: Naproxen 250mg (100 & 500 count bottles), Naproxen 375mg (100 & 500 count bottles), Naproxen 500mg (100 & 500 count bottles).

• Pricing: Offerors must submit prices for the base year and all four option years for all six line items. Prices must include a 0.5% Cost Recovery Fee.

• Manufacturer Requirements: Offerors not manufacturing the products must submit a Letter of Commitment from the manufacturer. The same manufacturer (NDA/ANDA/BLA) must be maintained throughout the contract period unless approved otherwise.

• Product Registration: Submitted product information, including NDC, must be registered with FDA, First Databank, Medispan, and Cerner Multum within five days of award.

• Packaging & Labeling: Specific packaging requirements include safety caps for bottles of 400 tablets or less, compatibility with automated dispensing units, and no glass bottles. Unique NDC numbers must be on the offeror's label.

• Bar Coding: All pharmaceutical products require GS1-128 or HIBCC compliant bar code labeling at the unit-of-use package level, encoding the NDC.

• DSCSA Requirements: Compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory, including serialized DSCSA Transaction Information and Transaction Statements using GS1 EPCIS files.

• cGMP Compliance: Manufacturing facilities must have an acceptable current Good Manufacturing Practices (cGMP) status with the FDA.

• Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.

• Contract Duration: Base ordering period of one year, with four one-year pre-priced option ordering periods.

• Payment Structure: Contractors will receive payments from PPV programs, not directly from the Government. Assignment of payment rights is not permitted.

• Submission Method: Proposals accepted via email in Microsoft Word or PDF format, including a scanned SF-1449. Faxed proposals are not acceptable.

• Deadline: Offerors must submit proposals by the exact time specified in the solicitation. Late submissions will not be considered unless specific exceptions apply.

• Evaluation: Award will be made to the responsible offeror with the lowest price technically acceptable offer. Technical acceptability includes meeting product descriptions, unique NDC requirements, FDA approval, FDA cGMP compliance, and manufacturing facility clearance. Price evaluation will be based on the total evaluated price for the base year and all option years.

• Subcontracting Plan: Non-small business concerns must submit an approved subcontracting plan for contracts over $900,000.

• SAM Registration: Prospective contractors must maintain current and accurate records in the System for Award Management (SAM).

• The solicitation references several attachments (A, B, C, D) for PPV contractor details, estimated annual requirements, and subcontracting plan templates.

• Offerors must price all six line items for the base year and all four option years to be considered for award.

Solicitation / RFP / RFQ

This is a pre-solicitation notice for an upcoming Request for Proposal (RFP) for Naproxen Tablets. The Department of Veterans Affairs (VA) National Acquisition Center intends to procure these tablets for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The goal is to award a single contract to a responsible offeror capable of providing an uninterrupted source of supply.

• Procurement of Naproxen Tablets in various strengths and package sizes.

• Offerors must state the exact drug name (as it appears on the label) and provide a unique NDC/UPC number.

• Standard package unit of use is bottles.

• Contract items will be distributed through the VA’s Pharmaceutical Prime Vendor Programs.

• Contract type: Not specified, but issued in commercial item format per FAR Part 12.

• Period of Performance: One base year plus four one-year option periods.

• Solicitation Number: 36E79726R0011

• Solicitation Issue Date: On or about February 10, 2026.

• Response Date/Time/Zone: February 24, 2026, 2:30 PM Central Time, Chicago, USA.

• Submission Method: Electronically issued at www.beta.sam.gov. No paper copies will be available.

• Interested offerors are advised to continuously check the URL for changes.

• All responsible sources may submit an offer.

• Unrestrictive procurement.

• NAICS Code: 325412

• Product Service Code: 6505

• Estimated Annual Usage (Bottles):

  • Naproxen 250MG TAB (100 count): 4,420
  • Naproxen 250MG TAB (500 count): 14,256
  • Naproxen 375MG TAB (100 count): 1,476
  • Naproxen 375MG TAB (500 count): 8,553
  • Naproxen 500MG TAB (100 count): 8,994
  • Naproxen 500MG TAB (500 count): 115,664

• Point of Contact: Michael Olszewski (michael.olszewski@va.gov, 708-786-4966)